Detailed information for compound 303246

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 518.424 | Formula: C24H21F7N2O3
  • H donors: 2 H acceptors: 4 LogP: 5.36 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)CO)C(C(C(F)(F)F)(F)F)(F)F
  • InChi: 1S/C24H21F7N2O3/c1-2-5-19-32-20(22(25,26)23(27,28)24(29,30)31)18(13-34)33(19)12-14-8-10-15(11-9-14)16-6-3-4-7-17(16)21(35)36/h3-4,6-11,34H,2,5,12-13H2,1H3,(H,35,36)
  • InChiKey: DTYMKUJLOVSLKP-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Angiotensin II receptor Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma japonicum ko:K04134 cholinergic receptor, invertebrate, putative Angiotensin II receptor   359 aa 336 aa 22.3 %
Echinococcus multilocularis growth hormone secretagogue receptor type 1 Angiotensin II receptor   359 aa 351 aa 21.9 %
Echinococcus granulosus growth hormone secretagogue receptor type 1 Angiotensin II receptor   359 aa 351 aa 21.9 %
Loa Loa (eye worm) hypothetical protein Angiotensin II receptor   359 aa 330 aa 26.7 %
Onchocerca volvulus Angiotensin II receptor   359 aa 386 aa 24.9 %
Onchocerca volvulus Angiotensin II receptor   359 aa 312 aa 19.2 %
Schistosoma japonicum Rhodopsin, putative Angiotensin II receptor   359 aa 327 aa 24.2 %
Schistosoma mansoni opsin-like receptor Angiotensin II receptor   359 aa 299 aa 25.1 %
Echinococcus granulosus pyroglutamylated rfamide peptide receptor Angiotensin II receptor   359 aa 407 aa 19.4 %
Echinococcus multilocularis tm gpcr rhodopsin gpcr rhodopsin superfamily Angiotensin II receptor   359 aa 303 aa 22.4 %
Schistosoma mansoni adenoreceptor Angiotensin II receptor   359 aa 329 aa 24.0 %
Onchocerca volvulus Angiotensin II receptor   359 aa 303 aa 25.1 %
Brugia malayi putative neuropeptide receptor NPR1 Angiotensin II receptor   359 aa 295 aa 27.5 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Angiotensin II receptor   359 aa 334 aa 23.7 %
Onchocerca volvulus Angiotensin II receptor   359 aa 294 aa 23.8 %
Echinococcus granulosus thyrotropin releasing hormone receptor Angiotensin II receptor   359 aa 337 aa 24.0 %
Brugia malayi ORL1-like opioid receptor Angiotensin II receptor   359 aa 314 aa 20.1 %
Schistosoma mansoni peptide (allatostatin)-like receptor Angiotensin II receptor   359 aa 314 aa 26.1 %
Schistosoma mansoni peptide (FMRFamide/somatostatin)-like receptor Angiotensin II receptor   359 aa 346 aa 18.2 %
Onchocerca volvulus E3 ubiquitin-protein ligase rpm-1 homolog Angiotensin II receptor   359 aa 352 aa 20.5 %
Brugia malayi GnHR receptor homolog Angiotensin II receptor   359 aa 364 aa 20.9 %
Onchocerca volvulus Angiotensin II receptor   359 aa 314 aa 25.8 %
Echinococcus multilocularis G-protein coupled receptor, putative Angiotensin II receptor   359 aa 308 aa 22.4 %
Echinococcus multilocularis pyroglutamylated rfamide peptide receptor Angiotensin II receptor   359 aa 406 aa 20.0 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Angiotensin II receptor   359 aa 311 aa 23.5 %
Echinococcus granulosus allatostatin A receptor Angiotensin II receptor   359 aa 348 aa 25.9 %
Echinococcus granulosus neuropeptide receptor Angiotensin II receptor   359 aa 316 aa 25.0 %
Onchocerca volvulus Angiotensin II receptor   359 aa 395 aa 23.0 %
Echinococcus multilocularis neuropeptide receptor Angiotensin II receptor   359 aa 316 aa 25.3 %
Echinococcus multilocularis allatostatin A receptor Angiotensin II receptor   359 aa 348 aa 25.9 %
Echinococcus granulosus tm gpcr rhodopsin Angiotensin II receptor   359 aa 303 aa 22.4 %
Loa Loa (eye worm) hypothetical protein Angiotensin II receptor   359 aa 335 aa 23.3 %
Loa Loa (eye worm) neuropeptide F receptor Angiotensin II receptor   359 aa 356 aa 24.2 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi metallo-peptidase, Clan MG, Family M24 0.0273 1 1
Trichomonas vaginalis Clan MG, familly M24, aminopeptidase P-like metallopeptidase 0.0273 1 1
Leishmania major methionine aminopeptidase 2, putative 0.0273 1 1
Trypanosoma cruzi metallo-peptidase, Clan MG, Family M24 0.0273 1 1
Mycobacterium tuberculosis Dipeptidase PepE 0.0034 0 0.5
Onchocerca volvulus Methionine aminopeptidase 2 homolog 0.0273 1 1
Mycobacterium ulcerans dipeptidase PepE 0.0034 0 0.5
Mycobacterium leprae Probable cytoplasmic peptidase PepQ 0.0034 0 0.5
Loa Loa (eye worm) initiation factor 2-associated protein 0.0273 1 1
Mycobacterium tuberculosis Probable cytoplasmic peptidase PepQ 0.0034 0 0.5
Trichomonas vaginalis Clan MG, familly M24, aminopeptidase P-like metallopeptidase 0.0273 1 1
Mycobacterium ulcerans aminopeptidase 0.0034 0 0.5
Mycobacterium ulcerans methionine aminopeptidase 0.0034 0 0.5
Wolbachia endosymbiont of Brugia malayi Xaa-Pro aminopeptidase 0.0034 0 0.5
Chlamydia trachomatis methionine aminopeptidase 0.0034 0 0.5
Treponema pallidum aminopeptidase P 0.0034 0 0.5
Trypanosoma brucei methionine aminopeptidase 2, putative 0.0273 1 1
Echinococcus multilocularis methionyl aminopeptidase 2 0.0273 1 1
Chlamydia trachomatis aminopeptidase P 0.0034 0 0.5
Plasmodium falciparum methionine aminopeptidase 2 0.0273 1 1
Wolbachia endosymbiont of Brugia malayi methionine aminopeptidase 0.0034 0 0.5
Entamoeba histolytica methionine aminopeptidase, putative 0.0273 1 1
Trypanosoma brucei metallo-peptidase, Clan MG, Family M24 0.0273 1 1
Giardia lamblia Methionine aminopeptidase 0.0273 1 1
Trichomonas vaginalis Clan MG, familly M24, aminopeptidase P-like metallopeptidase 0.0273 1 1
Schistosoma mansoni methionyl aminopeptidase 2 (M24 family) 0.0273 1 1
Mycobacterium tuberculosis Methionine aminopeptidase MapB (map) (peptidase M) 0.0034 0 0.5
Trichomonas vaginalis Clan MG, familly M24, aminopeptidase P-like metallopeptidase 0.0273 1 1
Mycobacterium ulcerans cytoplasmic peptidase PepQ 0.0034 0 0.5
Mycobacterium leprae PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) 0.0034 0 0.5
Mycobacterium ulcerans methionine aminopeptidase MapB 0.0034 0 0.5
Treponema pallidum methionine aminopeptidase (map) 0.0034 0 0.5
Mycobacterium ulcerans dipeptidase 0.0034 0 0.5
Mycobacterium tuberculosis Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) 0.0034 0 0.5
Mycobacterium leprae PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) 0.0034 0 0.5
Echinococcus granulosus methionyl aminopeptidase 2 0.0273 1 1
Toxoplasma gondii methionine aminopeptidase 2, putative 0.0273 1 1
Plasmodium vivax methionine aminopeptidase 2, putative 0.0273 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 74 nM Angiotensin II receptor antagonist activity was determined by 50% inhibition of specific binding of [3H]-angiotensin II (2 nM) to rat adrenal cortical microsomes ChEMBL. No reference
IC50 (binding) = 74 nM Angiotensin II receptor antagonist activity was determined by 50% inhibition of specific binding of [3H]-angiotensin II (2 nM) to rat adrenal cortical microsomes ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.